Aspirin Management for Total Knee Arthroplasty in Pacemaker Patient
Continue the baby aspirin through surgery without interruption. For this patient with a pacemaker on low-dose aspirin undergoing total knee arthroplasty, the cardiovascular risks of stopping aspirin far outweigh the minimal bleeding risks of continuation 1.
Primary Recommendation
The 2022 American College of Chest Physicians guidelines provide clear direction: aspirin should generally be continued perioperatively for non-cardiac surgery 1. When interruption is deemed necessary, they recommend stopping aspirin ≤7 days (not 7-10 days) before surgery 1. However, for your patient with a pacemaker—indicating underlying cardiac disease—continuation is the safer approach.
Key Evidence Supporting Continuation
Cardiovascular Risk vs. Bleeding Risk
- Aspirin withdrawal precedes up to 10.2% of acute cardiovascular syndromes, with acute coronary events occurring on average 8.5 days after discontinuation 2
- In total knee arthroplasty specifically, aspirin continuation does not increase surgical bleeding or transfusion rates 3, 4
- Multiple studies demonstrate that preoperative aspirin (even when discontinued 7 days prior) shows no significant difference in blood loss compared to controls 5
Total Joint Arthroplasty-Specific Data
Research directly addressing your clinical scenario shows:
- Aspirin increases bleeding complications by only a factor of 1.5 without increasing severity of bleeding (except in closed-space surgeries like intracranial or spinal canal procedures) 2
- Perioperative continuation of 100mg aspirin as part of DVT prophylaxis is safe, with no difference in blood loss, operative time, or wound healing 4
- Two patients experienced acute MI and stroke when aspirin was discontinued preoperatively for knee arthroplasty, while continuation caused no excess bleeding 3
Clinical Algorithm
For your patient:
- Continue aspirin 81mg daily through surgery (including the morning of surgery)
- Resume immediately postoperatively once hemostasis is confirmed
- This approach provides both cardiovascular protection AND adequate VTE prophylaxis 6, 7
Important Caveats
The guideline acknowledges modification for "high-bleed-risk" surgeries in closed spaces (intracranial, spinal canal, posterior eye chamber) where 7-day interruption may be considered 1. Total knee arthroplasty does not fall into this category.
The pacemaker placement 6 months ago indicates significant cardiovascular disease, making this patient particularly vulnerable to thrombotic complications from aspirin withdrawal. The thrombotic risk overwhelms any theoretical benefit of stopping aspirin 8.
Practical Implementation
- Do not hold the aspirin
- Inform the surgical and anesthesia teams of continuation
- Ensure adequate hemostasis intraoperatively
- The patient's cardiac history makes them higher risk for thrombotic events than bleeding complications
- Fresh platelets are available if unexpected severe bleeding occurs (though this is exceedingly rare) 8
The evidence strongly supports that stopping aspirin creates more harm than benefit in this clinical scenario 3, 2.